Crossmark

The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats’ disease

Crossref DOI link: https://doi.org/10.1007/s00417-018-3949-1

Published Online: 2018-03-16

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Longli

Ke, Yifeng

Wang, Wei

Shi, Xueying

Hei, Kaiwen

Li, Xiaorong https://orcid.org/0000-0002-4367-2523
Funding

Funding for this research was provided by:

Natural Science Foundation of Tianjin City (16JCQNJC12700)

Natural Science Foundation of Tianjin City (15JCZDJC34500)

National Natural Science Foundation of China (81500745)

National Natural Science Foundation of China (81670875)
License Information

Text and Data Mining valid from 2018-03-16
More Information

Article History

Received: 15 November 2017

Revised: 5 February 2018

Accepted: 1 March 2018

First Online: 16 March 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Tianjin Medical University Eye Hospital and Hebei Eye Hospital) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: For this type of study, formal consent is not required.